Healthcare - Medical - Devices - NYSE - US
$ 67.76
2.42 %
$ 40 B
Market Cap
26.16
P/E
CASH FLOW STATEMENT
896 M
OPERATING CASH FLOW
174 M
INVESTING CASH FLOW
-711 M
FINANCING CASH FLOW
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis
Edwards Lifesciences Corporation
| Net Income | 1.4 B |
| Depreciation & Amortization | 145 M |
| Capital Expenditures | -266 M |
| Stock-Based Compensation | 139 M |
| Change in Working Capital | -526 M |
| Others | -232 M |
| Free Cash Flow | 630 M |
Cash Flow
Millions
| Dec-2023 | Dec-2022 | Dec-2021 | Dec-2020 | Dec-2019 | Dec-2018 | Dec-2017 | Dec-2016 | Dec-2015 | Dec-2014 | Dec-2013 | Dec-2012 | Dec-2011 | Dec-2010 | Dec-2009 | Dec-2008 | Dec-2007 | Dec-2006 | Dec-2005 | Dec-2004 | Dec-2003 | Dec-2002 | Dec-2001 | Dec-2000 | Dec-1999 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| OPERATING CASH FLOW | |||||||||||||||||||||||||
| Net Income | 1 399.4 | 1 521.9 | 1 503.1 | 823.4 | 1 046.9 | 722.2 | 583.6 | 569.5 | 494.9 | 811.1 | 391.7 | 293.2 | 236.7 | 218.0 | 229.1 | 128.9 | 113.0 | 130.5 | 79.3 | 1.7 | 79.0 | 55.7 | (11.0) | (272.0) | 82.0 |
| Depreciation & Amortization | 144.9 | 139.6 | 134.8 | 107.2 | 89.3 | 77.4 | 81.9 | 71.2 | 65.8 | 68.6 | 68.7 | 57.3 | 58.0 | 56.5 | 58.7 | 55.6 | 54.8 | 56.8 | 56.2 | 55.7 | 45.6 | 40.4 | 57.0 | 74.0 | 84.0 |
| Deferred Income Tax | (272.1) | (254.5) | (41.4) | (49.4) | 12.1 | (27.3) | 17.8 | (37.4) | (95.0) | (71.1) | 100 K | 8.1 | (0.6) | (11.2) | (4.0) | (23.5) | (5.6) | 7.1 | (13.8) | 0.8 | 5.3 | (13.8) | (30.0) | 0 | 0 |
| Stock Based Compensation | 139.4 | 126.8 | 109.3 | 92.6 | 81.3 | 71.0 | 61.6 | 56.9 | 49.9 | 48.3 | 47.4 | 42.1 | 35.0 | 29.3 | 28.3 | 28.7 | 27.7 | 26.6 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Operating Activities | 10.5 | 105.8 | (119.0) | 38.3 | 154.1 | 126.1 | 21.6 | (21.9) | (30.3) | (24.9) | (56.7) | (38.4) | 15.1 | (40.1) | (78.5) | 33.0 | 16.2 | 24.7 | 18.7 | 119.6 | 12.3 | 74.6 | 8.0 | 347.0 | 11.0 |
| Change in Working Capital | (526.3) | (421.4) | 145.3 | 42.2 | (204.3) | (42.6) | 234.2 | 66.1 | 64.4 | 190.3 | 21.5 | 11.5 | (29.7) | (1.1) | (68.3) | (69.5) | 4.1 | (14.9) | (3.6) | 2.8 | (19.9) | (36.3) | (5.0) | (12.0) | (1.0) |
| Cash From Operations | 895.8 | 1 218.2 | 1 732.1 | 1 054.3 | 1 179.4 | 926.8 | 1 000.7 | 704.4 | 549.7 | 1 022.3 | 472.7 | 373.8 | 314.5 | 251.4 | 165.3 | 153.2 | 210.2 | 230.8 | 136.8 | 180.6 | 122.3 | 120.6 | 101.0 | 137.0 | 176.0 |
| INVESTING CASH FLOW | |||||||||||||||||||||||||
| Capital Expenditures | (266.3) | (264.8) | (329.8) | (407.3) | (278.4) | (241.7) | (175.5) | (217.4) | (106.5) | (93.7) | (110.1) | (127.7) | (90.6) | (63.0) | (64.0) | (78.0) | (62.5) | (59.4) | (48.5) | (42.5) | (37.9) | (40.7) | (38.0) | (46.0) | (42.0) |
| Other Items | 440.1 | 517.1 | (1 392.7) | (123.8) | (317.4) | 318.4 | (471.7) | 5.7 | (209.6) | (539.3) | (302.6) | 37.2 | (322.2) | 1.5 | 104.1 | 136.8 | (82.0) | 23.7 | 21.3 | (134.6) | (25.4) | (27.6) | 34.0 | (29.0) | (7.0) |
| Cash From Investing Activities | 173.8 | 252.3 | (1 722.5) | (531.1) | (595.8) | 76.7 | (647.2) | (211.7) | (316.1) | (633.0) | (412.7) | (90.5) | (412.8) | (61.5) | 40.1 | 58.8 | (144.5) | (35.7) | (27.2) | (177.1) | (63.3) | (68.3) | (4.0) | (75.0) | (49.0) |
| FINANCING CASH FLOW | |||||||||||||||||||||||||
| Common Stock Repurchased | (879.6) | (1 727.1) | (512.8) | (625.4) | (263.3) | (795.5) | (763.3) | (662.3) | (280.1) | (300.9) | (496.9) | (344.1) | (303.4) | (200.0) | (95.5) | (306.5) | (130.9) | (145.9) | (53.5) | (59.1) | (49.4) | (30.8) | 0 | 0 | 0 |
| Total Debt Repaid | (0.3) | (0.2) | (1.8) | (0.8) | (10.0) | (437.3) | 176.3 | 222.1 | 1.9 | (12.7) | 409.6 | 39.5 | 104.4 | (48.4) | (84.6) | 94.2 | (27.9) | (85.9) | 59.1 | 7.1 | (4.0) | (82.1) | (91.0) | 441.0 | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | 168.9 | 142.8 | 158.3 | 139.3 | 157.7 | 131.6 | 113.8 | 171.7 | 119.6 | 160.6 | 122.2 | 149.0 | 63.8 | 144.5 | 21.6 | 14.4 | 12.0 | 4.7 | (2.8) | 1.0 | (4.4) | 20.6 | 13.0 | (482.0) | (127.0) |
| Cash From Financing Activities | (711.0) | (1 584.5) | (356.3) | (486.9) | (115.6) | (1 101.2) | (473.2) | (268.5) | (158.6) | (153.0) | 34.9 | (155.6) | (135.2) | (103.9) | (91.8) | (134.1) | (108.1) | (193.6) | 29.0 | (20.5) | (15.0) | (69.5) | (78.0) | (37.0) | (127.0) |
| CHANGE IN CASH | |||||||||||||||||||||||||
| Net Change In Cash | 375.4 | (94.8) | (332.8) | 15.8 | 465.0 | (104.2) | (111.8) | 211.7 | 64.6 | 233.4 | 109.5 | 139.7 | (224.9) | 62.0 | 115.4 | 76.9 | (41.0) | 4.2 | 129.7 | (12.2) | 26.9 | (13.5) | 20.0 | 28.0 | 0 |
| FREE CASH FLOW | |||||||||||||||||||||||||
| Free Cash Flow | 629.5 | 953.4 | 1 402.3 | 647.0 | 901.0 | 685.1 | 825.2 | 487.0 | 443.2 | 928.6 | 362.6 | 246.1 | 223.9 | 188.4 | 101.3 | 75.2 | 147.7 | 171.4 | 88.3 | 138.1 | 84.4 | 79.9 | 63.0 | 91.0 | 134.0 |